Amplitude Surgical Stock

Amplitude Surgical ROE 2025

Amplitude Surgical ROE

0.02

Ticker

AMPLI.PA

ISIN

FR0012789667

WKN

A14UZ2

In 2025, Amplitude Surgical's return on equity (ROE) was 0.02, a -96.11% increase from the 0.41 ROE in the previous year.

Amplitude Surgical Aktienanalyse

What does Amplitude Surgical do?

Amplitude Surgical SA is a leading company in the field of orthopedic implants based in France. It was founded in 1997 by Olivier Jallabert and has since become an important player in the market. The company has a wide portfolio of products for orthopedic surgery, including implants for hip, knee, and shoulder operations, as well as instruments and equipment for surgical care. Amplitude Surgical SA has developed a number of product innovations over the years, including the Octave system, an advanced prosthetic hip solution with a unique filling technology, and the TriLock system, an advanced knee implant. The company distributes its products worldwide through a network of subsidiaries and partner companies in Europe, Asia, the Middle East, Africa, and America. It has a strong presence in Europe and is also active in emerging markets such as China and India. The business model is based on the development of new products and innovations that meet the needs of patients and surgeons. The company has a strong commitment to research and development and continually invests in the development of new technologies and solutions. It has an extensive product pipeline and works closely with leading surgeons and research institutions to ensure that it remains at the forefront of the field. Amplitude Surgical SA also specializes in training and supporting surgeons to ensure that they understand and can apply the latest technologies and techniques. The company offers a variety of training programs to ensure that surgeons are familiar with its products and solutions and can use them safely and effectively. Amplitude Surgical SA is divided into several divisions that focus on various areas of orthopedic surgery. The main divisions include hip and surface replacement, knee replacement, shoulder replacement, as well as instruments and implants for sports medicine. The hip and surface replacement division of Amplitude Surgical SA offers a wide range of products for the surgical treatment of hip joints and bone defects. The company has developed innovative implant solutions such as the Fitmore hip system, specifically designed for minimally invasive hip surgery. The knee replacement division of Amplitude Surgical SA offers a wide range of implants and instruments for the treatment of knee joints. The main product lines include the TriLock knee implant and the Amplivision instrument system. The shoulder replacement division of Amplitude Surgical SA offers a variety of implantable and non-invasive implants and instruments for the surgical treatment of shoulder injuries and diseases. The main product lines include the DoubleUP shoulder stabilizer and the drilling and screw systems for acromioclavicular joint injuries. The sports medicine division of Amplitude Surgical SA offers a wide range of implants and instruments for the treatment of sports injuries and overuse injuries. The main product lines include the Bi-Plate Multilocket system for ankle injury care and the CleatLock ACL system for cruciate ligament injury care. Overall, Amplitude Surgical SA is a leading company in the field of orthopedic implants, offering a wide range of solutions for surgeons and patients worldwide. With a strong commitment to research and development and a dedicated team of professionals, the company is well positioned to continue offering innovative solutions for a variety of orthopedic conditions and injuries. Amplitude Surgical ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Amplitude Surgical's Return on Equity (ROE)

Amplitude Surgical's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Amplitude Surgical's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Amplitude Surgical's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Amplitude Surgical’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Amplitude Surgical stock

What is the ROE (Return on Equity) of Amplitude Surgical this year?

The ROE of Amplitude Surgical this year is 0.02 undefined.

How has the Return on Equity (ROE) of Amplitude Surgical developed compared to the previous year?

The ROE of Amplitude Surgical has increased by -96.11% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Amplitude Surgical?

A high ROE indicates that Amplitude Surgical generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Amplitude Surgical?

A low ROE can indicate that Amplitude Surgical is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Amplitude Surgical affect the company?

A change in ROE (Return on Equity) of Amplitude Surgical can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Amplitude Surgical?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Amplitude Surgical?

Some factors that can influence Amplitude Surgical's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Amplitude Surgical pay?

Over the past 12 months, Amplitude Surgical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Amplitude Surgical is expected to pay a dividend of 0 EUR.

What is the dividend yield of Amplitude Surgical?

The current dividend yield of Amplitude Surgical is .

When does Amplitude Surgical pay dividends?

Amplitude Surgical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Amplitude Surgical?

Amplitude Surgical paid dividends every year for the past 0 years.

What is the dividend of Amplitude Surgical?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Amplitude Surgical located?

Amplitude Surgical is assigned to the 'Health' sector.

Wann musste ich die Aktien von Amplitude Surgical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Amplitude Surgical from 5/2/2025 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 5/2/2025.

When did Amplitude Surgical pay the last dividend?

The last dividend was paid out on 5/2/2025.

What was the dividend of Amplitude Surgical in the year 2024?

In the year 2024, Amplitude Surgical distributed 0 EUR as dividends.

In which currency does Amplitude Surgical pay out the dividend?

The dividends of Amplitude Surgical are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Amplitude Surgical

Our stock analysis for Amplitude Surgical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Amplitude Surgical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.